Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

178.06 +0.89 (+0.50%)
Official Closing Price Updated: 7:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Market Jitters: Wall Street Braces for Continued Volatility
The U.S. stock market is once again sending signals of caution, as major indices experienced a notable pullback from their recent record highs in early September 2025. This downturn, following a robust... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson Showcases Positive AFib Data, Treatment Results
Johnson & Johnson data shows VARIPULSE safety in AF procedures and Impella CP's long-term survival benefit in cardiogenic shock. 
Via Benzinga
Is Healthcare Setting Up to Be a Quiet Leader Into Year-End?
Over $11 billion flowed into the popular healthcare sector ETF XLV in Q2 alone, suggesting smart money is positioning for a potential rebound. 
Via MarketBeat
Topics ETFs
These 4 Dividend Stocks Are Money-Printing Machines
These companies generate lots of cash to pass on to shareholders. 
Via The Motley Fool
The Great Rebalancing: Equity Markets Pivot from Tech Giants to Value and Cyclical Stocks
A significant sector rotation is currently underway in equity markets, shifting investor capital away from the mega-cap technology stocks that dominated recent years towards more traditional value and... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
Johnson & Johnson ended a Phase 2a study of nipocalimab in rheumatoid arthritis after no added benefit was seen, but remains confident in its market potential. 
Via Benzinga
Global Trade Braces for Impact: US-China Tariff Tensions Persist Amidst Fleeting Truces and Escalating Duties
The global economic landscape remains deeply entrenched in a complex and often volatile trade conflict between the United States and China. What began in January 2018 as a series of targeted duties has... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Navigating the Tempest: Why Diversification and Active Management are Paramount in Today's Volatile Markets
The global financial markets are currently navigating a tempest of elevated volatility and profound uncertainty, a landscape that has become the new normal for investors worldwide. From persistent... 
Via MarketMinute
Topics Bonds ETFs Economy
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy... 
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big
EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost. 
Via Benzinga
Topics World Trade
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,... 
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
The $7 Trillion Question: A Tidal Wave of Capital Poised to Reshape Stock Markets
An unprecedented sum of approximately $7.19 trillion currently sits in money market funds, a colossal reservoir of capital that has captivated the attention of financial strategists worldwide. This... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Inflationary Pressures Persist: Navigating a Slowing Economy and Weakening Labor Market
The United States economy finds itself at a critical juncture in August 2025, grappling with a stubborn inflation problem that continues to defy the Federal Reserve's targets, even as clear signs of an... 
Via MarketMinute
Topics Economy World Trade
As the Market Rotates, This Healthcare ETF Is Leading the Way
Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure. 
Via MarketBeat
Topics ETFs
Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock with Strong Fundamentals
Discover Johnson & Johnson (JNJ), a top dividend stock with a strong 2.91% yield, consistent growth, and solid financial health for reliable income. 
Via Chartmill
U.S. Leading Economic Index Dips: A Harbinger of Economic Slowdown or a False Alarm?
The U.S. Leading Economic Index (LEI) has experienced a consistent decline in recent months, sparking concerns about the nation's economic trajectory for the second half of 2025. While the current... 
Via MarketMinute
Topics Economy Supply Chain World Trade
Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts
Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut. 
Via MarketBeat
Topics ETFs Economy
Bridgewater, Once Led By Ray Dalio, Exits Alibaba, JD, PDD And Baidu, Dumping All US-listed Chinese Stocks Amid Geopolitical Risks
Bridgewater's Q2 filing shows a full exit from Chinese stocks like Alibaba, as new management bets big on NVIDIA & JNJ. See all the shifts. 
Via Benzinga
3 Dividend Growth Leaders to Buy Now
Via MarketBeat
Topics ETFs Economy World Trade
JNJ Stock Surge Signals Confidence in New Growth Path
Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions. 
Via MarketBeat
Topics Lawsuit
Got $500? 3 Dividend Stocks to Buy and Hold Forever
If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000). 
Via The Motley Fool
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low. 
Via The Motley Fool
Topics ETFs Stocks
2 Dividend Stocks Worth Doubling Down on Right Now
These healthcare giants can survive the toughest challenges. 
Via The Motley Fool
Topics World Trade
The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfolio
Massive growth stocks are driving the performance of the S&P 500, for better or for worse. 
Via The Motley Fool
Topics Economy Stocks
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF. 
Via The Motley Fool
Topics ETFs Stocks
Navigating the Peaks and Valleys: A Deep Dive into US Equity Market Valuations
The US equity market in mid-2025 presents a complex and often contradictory landscape for investors. While the S&P 500 has flirted with all-time highs, fueled by optimistic economic data and the... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
U.S. Economy Navigates Divergent Signals: Downward Revisions for 2025 Clash with Stronger Q3 Outlook
The U.S. economy finds itself at a crossroads, grappling with a complex interplay of growth projections. Recent downward revisions for 2025, coupled with a notable contraction in the first quarter of... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs
Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs... 
Via Benzinga
Topics Government World Trade
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
Names you've heard of with track records to love. 
Via The Motley Fool
Topics Retirement
9 Analysts Have This To Say About Johnson & Johnson
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.